Ascendis Pharma Income from Continuous Operations 2015-2024 | ASND
Ascendis Pharma income from continuous operations for the twelve months ending December 31, 2024 was $-0.409B, a 21.48% decline year-over-year.
- Ascendis Pharma annual income from continuous operations for 2024 was $-0.409B, a 21.48% decline from 2023.
- Ascendis Pharma annual income from continuous operations for 2023 was $-0.521B, a 15.2% decline from 2022.
- Ascendis Pharma annual income from continuous operations for 2022 was $-0.614B, a 35.4% increase from 2021.